The benefits are real, but so are the nutritional tradeoffs that come with long-term use
This strategy aligns with the industry view that medication alone is not a standalone solution for the complex, chronic condition of obesity
Based on a recent systematic review of the literature, MIS-C has distinct characteristics when compared to KD, such as more prevalent respiratory and gastrointestinal involvement, shock, increased incidence of cardiac complications, reduced incidence of conjunctival inflammatory symptoms, and elevated levels of inflammatory markers, myocardial injury markers, and creatine
Additionally, diabetes patients are more prone to experiencing blood glucose fluctuations and diabetes-related complications as adverse events
This is because it has the same ingredient as Wegovy, which is approved for weight management